OpenURL Connection Search

Select item for more details and to access through your institution.

Biology and management of rare primary extranodal T-cell lymphomas.
Published in:
2010
By:
- Roschewski M;
- Wilson WH
Publication type:
Journal Article
Racial disparities in the prevalence of monoclonal gammopathies: a population-based study of 12,482 persons from the National Health and Nutritional Examination Survey.
Published in:
2014
By:
- Landgren, O;
- Graubard, B I;
- Katzmann, J A;
- Kyle, R A;
- Ahmadizadeh, I;
- Clark, R;
- Kumar, S K;
- Dispenzieri, A;
- Greenberg, A J;
- Therneau, T M;
- Melton 3rd, L J;
- Caporaso, N;
- Korde, N;
- Roschewski, M;
- Costello, R;
- McQuillan, G M;
- Rajkumar, S V;
- Melton, L J 3rd
Publication type:
journal article
Racial disparities in the prevalence of monoclonal gammopathies: a population-based study of 12 482 persons from the National Health and Nutritional Examination Survey.
Published in:
Leukemia (08876924), 2014, v. 28, n. 7, p. 1537, doi. 10.1038/leu.2014.34
By:
- Landgren, O;
- Graubard, B I;
- Katzmann, J A;
- Kyle, R A;
- Ahmadizadeh, I;
- Clark, R;
- Kumar, S K;
- Dispenzieri, A;
- Greenberg, A J;
- Therneau, T M;
- Melton, L J;
- Caporaso, N;
- Korde, N;
- Roschewski, M;
- Costello, R;
- McQuillan, G M;
- Rajkumar, S V
Publication type:
Article
Phase I study of ON 01910.Na (Rigosertib), a multikinase PI3K inhibitor in relapsed/refractory B-cell malignancies.
Published in:
Leukemia (08876924), 2013, v. 27, n. 9, p. 1920, doi. 10.1038/leu.2013.79
By:
- Roschewski, M;
- Farooqui, M;
- Aue, G;
- Wilhelm, F;
- Wiestner, A
Publication type:
Article
PHASE 2 STUDY OF IBRUTINIB WITH TEMOZOLOMIDE, ETOPOSIDE, LIPOSOMAL DOXORUBICIN, DEXAMETHASONE, RITUXIMAB (TEDDI‐R) FOR SECONDARY CNS LYMPHOMA.
Published in:
Hematological Oncology, 2023, v. 41, p. 44, doi. 10.1002/hon.3163_17
By:
- Roschewski, M.;
- Simard, J.;
- Melani, C.;
- Lakhotia, R.;
- Phelan, J. D.;
- Pittaluga, S.;
- Muppidi, J. R.;
- Lionakis, M. S.;
- Peer, C.;
- Pradhan, A.;
- Holdhoff, M.;
- Swinnen, L. J.;
- Dunleavy, K.;
- Lai, C.;
- Ibrahimi, S.;
- Glantz, M.;
- Butman, J. A.;
- Johnson, K.;
- Steinberg, S. M.;
- Figg, W. D.
Publication type:
Article
MRD‐NEGATIVITY AFTER FRONTLINE DLBCL THERAPY: POOLED ANALYSIS OF 6 CLINICAL TRIALS.
Published in:
Hematological Oncology, 2023, v. 41, p. 177, doi. 10.1002/hon.3163_112
By:
- Roschewski, M.;
- Kurtz, D. M.;
- Westin, J.;
- Lynch, R. C.;
- Alig, S. K.;
- Macaulay, C.;
- Kuffer, C.;
- Hogan, G. J.;
- Schultz, A.;
- Close, S.;
- Chabon, J. J.;
- Rossi, D.;
- Opat, S.;
- Hicks, R.;
- Hertzberg, M. S.;
- Diehn, M.;
- Wilson, W.;
- Alizadeh, A. A.
Publication type:
Article
PHASED VARIANTS IMPROVE DLBCL MINIMAL RESIDUAL DISEASE DETECTION AT THE END OF THERAPY.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.25_2879
By:
- Kurtz, D. M;
- Chabon, J. J;
- Soo, J;
- Co Ting Keh, L;
- Alig, S;
- Schultz, A;
- Jin, M. C;
- Scherer, F;
- Craig, A. F. M;
- Liu, C. L;
- Dührsen, U;
- Hüttmann, A;
- Casasnovas, R.‐O;
- Westin, J. R;
- Roschewski, M;
- Wilson, W. H;
- Gaidano, G;
- Rossi, D;
- Diehn, M;
- Alizadeh, A. A
Publication type:
Article
THE FIRST‐IN‐CLASS ANTI‐CD47 ANTIBODY HU5F9‐G4 + RITUXIMAB INDUCES DURABLE RESPONSES IN RELAPSED/REFRACTORY DLBCL AND INDOLENT LYMPHOMA: INTERIM PHASE 1B/2 RESULTS.
Published in:
Hematological Oncology, 2019, v. 37, p. 89, doi. 10.1002/hon.57_2629
By:
- Advani, R.;
- Bartlett, N.L.;
- Smith, S.M.;
- Roschewski, M.;
- Popplewell, L.;
- Flinn, I.;
- Collins, G.;
- Ghosh, N.;
- LaCasce, A.;
- Asch, A.;
- Kline, J.;
- Kesevan, M.;
- Tran, T.;
- Lynn, J.;
- Huang, J.;
- Agoram, B.;
- Volkmer, J.;
- Takimoto, C.H.;
- Chao, M.P.;
- Mehta, A.
Publication type:
Article
THE FIRST‐IN‐CLASS ANTI‐CD47 ANTIBODY HU5F9‐G4 + RITUXIMAB INDUCES DURABLE RESPONSES IN RELAPSED/REFRACTORY DLBCL AND INDOLENT LYMPHOMA: INTERIM PHASE 1B/2 RESULTS.
Published in:
Hematological Oncology, 2019, v. 37, p. 89, doi. 10.1002/hon.57_2629
By:
- Advani, R.;
- Bartlett, N.L.;
- Smith, S.M.;
- Roschewski, M.;
- Popplewell, L.;
- Flinn, I.;
- Collins, G.;
- Ghosh, N.;
- LaCasce, A.;
- Asch, A.;
- Kline, J.;
- Kesevan, M.;
- Tran, T.;
- Lynn, J.;
- Huang, J.;
- Agoram, B.;
- Volkmer, J.;
- Takimoto, C.H.;
- Chao, M.P.;
- Mehta, A.
Publication type:
Article
RISK-ADAPTED THERAPY IN ADULTS WITH BURKITT LYMPHOMA: UPDATED RESULTS OF a MULTICENTER PROSPECTIVE PHASE II STUDY OF DA-EPOCH-R.
Published in:
Hematological Oncology, 2017, v. 35, p. 133, doi. 10.1002/hon.2437_122
By:
- Dunleavy, K.;
- Roschewski, M.;
- Abramson, J.S.;
- Link, B.;
- Parekh, S.;
- Jagadeesh, D.;
- Bierman, P.;
- Watson, P.R.;
- Peace, D.;
- Hanna, W.;
- Powell, B.;
- Melani, C.;
- Lucas, A.;
- Steinberg, S.M.;
- Kahl, B.;
- Friedberg, J.W.;
- Little, R.F.;
- Bartlett, N.L.;
- Fanale, M.A.;
- Noy, A.
Publication type:
Article

Found: 10